Lipids and Cholesterol

Latest

Statin Treatment Beneficial for High-Risk Patients Despite Adverse Reactions

Statin Treatment Beneficial for High-Risk Patients Despite Adverse Reactions

From 25% to 50% of patients discontinue statins within 6 months to 1 year of starting, and the rate increases as high as 75% after 2 years.

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

Multiple clinical studies have examined the efficacy of pitavastatin.

Metabolic Concerns With Dutasteride Therapy for BPH

Metabolic Concerns With Dutasteride Therapy for BPH

Dutasteride therapy for benign prostatic hyperlasia has been linked to elevated HbA1c and LDL cholesterol.

Statin Intolerance Contributes to Higher Risk for MI and CHD

Statin Intolerance Contributes to Higher Risk for MI and CHD

Patients with statin intolerance had a 36% higher rate of recurrent MI compared to those with high statin adherence.

Effects of Sex-Dependent On-Treatment LDL Diferences on CVD Risk

Effects of Sex-Dependent On-Treatment LDL Diferences on CVD Risk

Women experienced the same CV benefits in statin trials, despite having slightly elevated on-treatment LDL cholesterol.

Incident CHD Risk Elevated With High Triglycerides, Low HDL

Incident CHD Risk Elevated With High Triglycerides, Low HDL

Risk of both ischemic stroke and coronary heart disease was elevated with high triglycerides and low high-density lipoprotein cholesterol.

Are Extremely Low LDL Cholesterol Levels Safe?

Are Extremely Low LDL Cholesterol Levels Safe?

Low levels of low-density lipoprotein cholesterol appear to be well tolerated on alirocumab therapy.

How Low is Too Low?: Safety and Tolerability of Extremely Low LDL Examined

How Low is Too Low?: Safety and Tolerability of Extremely Low LDL Examined

Data from 14 phase 2 and 3 studies were pooled to assess the safety of lowering LDL cholesterol with alirocumab.

Too Few Young Adults Are Prescribed Needed Statins

Too Few Young Adults Are Prescribed Needed Statins

Too few American young adults are receiving needed statin medications, according to findings published in JAMA Cardiology.

Fenofibrate Therapy Beneficial in Diabetes With Dyslipidemia

Fenofibrate Therapy Beneficial in Diabetes With Dyslipidemia

Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia.

Sign Up for Free e-Newsletters